Clinical trial
A Phase 1, Single And Multiple Ascending Dose, Food Effect, and Drug-Drug Interaction Study With Itraconazole, Midazolam and Fexofenadine Of Orally Administered AV078 In Healthy Adults
NCT06205381 is registered in ClinicalTrials.gov with Aeovian Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Single And Multiple Ascending Dose, Food Effect, and Drug-Drug Interaction Study With Itraconazole, Midazolam and Fexofenadine Of Orally Administered AV078 In Healthy Adults
- Lead sponsor
- Aeovian Pharmaceuticals, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2024
- Completion date
- February 8, 2025
- Enrollment
- 89 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
healthy participants